The University of Iowa will spend up to $15 million in fiscal year 2027 on a brain-science therapeutics program, cancer research labs, and a campus-wide secure research environment — with $3 million going to a hiring initiative that has already landed 93 faculty since 2021.

The largest single programmatic bet is the Iowa Program in Experimental Neurotherapies, a three-year, $600,000 interdisciplinary project that won a competitive campuswide call. It drew 18 proposals in fall 2025. The program targets both neurodevelopmental disorders and neurodegenerative disorders, and its explicit goals are translational: convert campus discoveries into treatments, strengthen competitiveness for large external grants, and attract partnerships with biotechnology, pharmaceutical, and medical-device companies.

"Our strategic plan challenges us to identify opportunities where the university can have the greatest impact," Executive Vice President and Provost Kevin Kregel said. "These investments support the people, infrastructure, and ideas that drive excellence in teaching, research, and creative scholarship while building capacity in areas that will shape the university's future."

Where does the $15 million actually go?

Roughly half funds infrastructure. Three projects account for $7 million:

• $3 million completes renovations to the Dance Building, the former Museum of Art building, which becomes home to the Department of Dance this fall.
• $3 million builds out the sixth floor of the College of Pharmacy Building into laboratory space for cancer researchers — the planned future home of the Iowa Institute for Cancer Drug Discovery and Development, pending Iowa Board of Regents approval. The College of Pharmacy, Holden Comprehensive Cancer Center, and donors add support beyond the P3 allocation.
• $1 million goes to HAWKTRUST, a university-wide secure research environment designed to meet emerging federal cybersecurity requirements, protect federally regulated information, and keep the university eligible for federal research opportunities.

The remaining $7.4 million supports strategic plan initiatives throughout the year. Of that, $3 million is designated for the High Impact Hiring Initiative, which funds faculty recruitment and retention in areas the university defines as excellence and impact priorities.

What is the track record?

The hiring initiative, launched in 2021, has supported 93 faculty recruitments and 35 retentions across 11 colleges — a metric administrators will likely cite as the program's measurable output. The SPARC Strategic Plan Implementation Fund, launched in FY2024, has supported 28 funding proposals to date, including 10 in FY2026.

Who pays, and for how long?

The money comes from the P3 program, funded by an endowment created in March 2020 when the university placed nearly $1 billion from its 50-year utility-system partnership with ENGIE North America and Meridiam into an endowment. Endowment earnings support roughly $15 million per fiscal year for strategic plan priorities — meaning FY2027's awards represent the program's standard annual capacity, not a one-time surge.

For R&D managers, the notable signals are two: the university is tying a small internal grant ($600,000 over three years, or $200,000 annually) explicitly to downstream external funding leverage and industry partnership, and it is treating cybersecurity compliance infrastructure as a prerequisite for federal research eligibility rather than an IT afterthought. The Regents' pending decision on the cancer drug discovery institute is the next milestone to watch.